Medical Device Developments Weekly
Medical Device Developments
Latest news and insight on innovations in the Medical Device sector.
Welcome to this week's Medical Device Developments newsletter.
See the latest insight and analysis from the global medical device market from the last week below:
Siemens Healthineers’ Atellica IM TnIH test gets FDA nod to predict cardiac events
The Atellica IM TnIH is a blood test designed to predict patient risk of cardiac events or death for up to one year.
The new test enhances care for at-risk cardiac patients in the US. It helps healthcare providers identify patients at risk of death and major cardiac events within a year of presenting with acute coronary syndrome symptoms.
Restore Robotics seeks FDA nod for Da Vinci Xi scissors remanufacturing
With the application, Restore Robotics, a surgical robotics company, is aiming to offer remanufactured robotic instruments that lower costs and enhance environmental sustainability.
By refurbishing original instruments for additional uses, hospitals can optimise their budgets and ensure access to the latest advancements in?robotic surgery?for their communities.
Boston Scientific gets FDA approval for Farawave catheter and Faraview software
The Farawave Nav Catheter and Faraview software jointly provide visualisation for cardiac ablation procedures with the Farapulse Pulsed Field Ablation (PFA) System.
The technologies are compatible with Boston Scientific’s existing cardiac mapping technology and its latest offering, the OPAL HDx Mapping System.
AI helps to detect antibiotic resistance, finds study by the University of Zurich
Researchers at the University of Zurich (UZH) have used artificial intelligence (AI) to help identify antibiotic-resistant bacteria. The team led by Adrian Egli , UZH professor at the Institute of Medical Microbiology, is the first to investigate how GPT-4, a powerful AI model developed by OpenAI , can be used to analyze antibiotic resistance.
Based on GPT-4, the scientists created the “EUCAST-GPT-expert”, which follows strict EUCAST (European Committee on Antimicrobial Susceptibility Testing) guidelines for interpreting antimicrobial resistance mechanisms.
领英推荐
Noom introduces innovative in-app body scan technology to monitor muscle-mass retention during GLP-1 treatment
Members can now complete a body scan by simply recording a 10-second video of themselves using the Noom app. The AI technology will analyze the footage to determine precise body composition measurements of the user’s body and provide a personalized 3D body avatar.
The machine-learning powered software platform calculates the user’s body composition, offering important health metrics such as body fat percentage, fat mass (lbs), waist-to-hip ratio and lean mass (lbs).
iRhythm Technologies, Inc. gets FDA 510(k) approval for design updates to Zio AT device
The Zio AT device is a prescription-only outpatient cardiac telemetry device, commonly known as a mobile cardiac telemetry device, used for mobile cardiac telemetry (MCT) services.
The system contains the Zio AT patch, an ECG monitor that continuously records ECG data for up to 14 days, and the company’s Zio ECG Utilization Software (ZEUS).
Upcoming webinars
Recommended webinars
Thanks for reading; we hope you enjoyed it.
Until next week.
To have a story featured on next week's newsletter - contact Medical Device Developments or Jamie Mann directly.
#MedicalDeviceDevelopments